Bjorn Kemper
Overview
Explore the profile of Bjorn Kemper including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1001
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Borrmann K, Troschel F, Brucksken K, Espinoza-Sanchez N, Rezaei M, Eder K, et al.
Antioxidants (Basel)
. 2024 Aug;
13(8).
PMID: 39199207
Reducing side effects in non-cancerous tissue is a key aim of modern radiotherapy. Here, we assessed whether the use of the antioxidants hydroxytyrosol (HT) and thioredoxin-mimetic peptide CB3 (TMP) attenuated...
2.
Picazo-Bueno J, Ketelhut S, Schnekenburger J, Mico V, Kemper B
J Biomed Opt
. 2024 Aug;
29(Suppl 2):S22715.
PMID: 39161785
Significance: Digital holographic microscopy (DHM) is a label-free microscopy technique that provides time-resolved quantitative phase imaging (QPI) by measuring the optical path delay of light induced by transparent biological samples....
3.
Marzi A, Eder K, Barroso A, Kemper B, Schnekenburger J
Cells
. 2024 Apr;
13(8.
PMID: 38667312
The assessment of nanoparticle cytotoxicity is challenging due to the lack of customized and standardized guidelines for nanoparticle testing. Nanoparticles, with their unique properties, can interfere with biochemical test methods,...
4.
Barroso A, Ketelhut S, Nettels-Hackert G, Heiduschka P, Amor R, Naranjo V, et al.
Biomed Opt Express
. 2023 Oct;
14(9):4421-4438.
PMID: 37791268
Durable and standardized phantoms with optical properties similar to native healthy and disease-like biological tissues are essential tools for the development, performance testing, calibration and comparison of label-free high-resolution optical...
5.
Haiduk T, Sicking M, Brucksken K, Espinoza-Sanchez N, Eder K, Kemper B, et al.
Arch Med Res
. 2023 Jul;
54(6):102855.
PMID: 37481823
Background And Aim: While preliminary evidence points to pro-tumorigenic roles for the Musashi (MSI) RNA-binding proteins Musashi-1 (MSI1) and Musashi-2 (MSI2) in some breast cancer subtypes, no data exist for...
6.
Picazo-Bueno J, Barroso A, Ketelhut S, Schnekenburger J, Mico V, Kemper B
Opt Lett
. 2023 Jun;
48(13):3615.
PMID: 37390194
This publisher's note contains corrections to Opt. Lett.48, 876 (2023)10.1364/OL.478674.
7.
Bokemeyer A, Buskermolen J, Ketelhut S, Tepasse P, Vollenberg R, Trebicka J, et al.
J Clin Med
. 2023 Jun;
12(12).
PMID: 37373760
Ulcerative colitis (UC) is characterized by chronic inflammation of the colorectum. Histological remission has emerged as a potential future treatment goal; however, the histopathological assessment of intestinal inflammation in UC...
8.
Wischmann F, Troschel F, Frankenberg M, Kemper B, Vijaya Kumar A, Sicking M, et al.
J Cancer Res Clin Oncol
. 2023 Apr;
149(11):8455-8465.
PMID: 37088795
Purpose: MicroRNA-218 (miR-218) is a key regulator of numerous processes relevant to tumor progression. In the present study, we aimed to characterize the relationship between miR-218 and the Epidermal Growth...
9.
Werth K, Kemper B, Kampmeier S, Mellmann A
Cells
. 2023 Mar;
12(5).
PMID: 36899897
Quantitative phase imaging (QPI) is a non-invasive, label-free technique used to detect aberrant cell morphologies caused by disease, thus providing a useful diagnostic approach. Here, we evaluated the potential of...
10.
Picazo-Bueno J, Barroso A, Ketelhut S, Schnekenburger J, Mico V, Kemper B
Opt Lett
. 2023 Feb;
48(4):876-879.
PMID: 36790964
We report on a single capture approach for simultaneous incoherent bright field (BF) and laser-based quantitative phase imaging (QPI). Common-path digital holographic microscopy (DHM) is implemented in parallel with BF...